Further correlation analysis showed there was a significantly negative correlation (Pearson r = −0.39, P = 0.033) between tumor size and CD8+Tem xCell score (Fig. 3H), implying the CD8+Tem could be the potential marker for the cetuximab sensitivity. This evidence concerns the gene CD8A and neoplasm.